H. Lundbeck Dividend yield

 Price  174.45
 Dividend  2.49
 Earnings  16.00
 Cash-flow  19.38
 Book value  87.23
 Equity  79.21

H. Lundbeck is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. H. Lundbeck is a company from Denmark, and his stocks are publicly traded.

H. Lundbeck paid a total dividend of 496 million DKK last year, for a market value of 34,716 millions (Market Cap 10,388 millions). Dividend per share of H. Lundbeck is 2.49 DKK, and his stock market price 174.45 DKK.

According to the chart below, where dividend yield is displayed, H. Lundbeck has a dividend yield of 1.43%, which is lower than the amount offered by the market average , but bigger than Health Care industry. Dividend yields are similar among companies from the same industry, so it is a positive sign for the company.

In addition, you should compare H. Lundbeck dividend yield with other Pharmaceuticals and Biotechnology companies or firms from Denmark.

Dividend yield of H. Lundbeck

H. Lundbeck Dividend Payout

About the ability of H. Lundbeck to maintain his current dividend of DKK 2.49 per share, an amount that accounts for 1.43%, we should study its payout ratio both on earnings and on cash-flows (see chart below). H. Lundbeck payout on ernings is currently 15.56%, which is lower than the market average and companies of Health Care industry, which are 39.27% and 31.41% respectively. Both figures lead us to believe that there is confidence that H. Lundbeckcan maintain his current dividend.

The payout on earnings should be complemented with the payout on cash flow since it is this last amount the one which can be distributed to shareholders. Cash flow per share of H. Lundbeck is DKK 19.38 per share, which is higher than the dividend per share paid by the company of DKK 2.49, so the company generates enough cash to maintain his dividend in the future.

The following figure shows payout ratios over earnings and cashflow of H. Lundbeck, compared againt world market average, Denmark companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.

H. Lundbeck payout

H. Lundbeck Dividend History

Year Yield  DKK  Paypout  Shares* 

*In millions

H. Lundbeck Stock performance

Finally, last moth H. Lundbeck showed a return of -6.20% compared to a worldwide -1.33% average, and a -3.33% of Health Care firms. Over the last year, the company obtained a -16.70% versus a worldwide performance of a 31.58%. More detailed information can be seen in the following graph for Denmark and Pharmaceuticals and Biotechnology firms.

H. Lundbeck stock and market return